SPARC Intraday Analysis...

SPARC Share Price

Open 497.75 Change Price %
High 504.10 1 Day 1.95 0.39
Low 488.40 1 Week -19.20 -3.72
Close 496.85 1 Month 51.60 11.59
Volume 196774 1 Year 166.90 50.58
52 Week High 532.00
52 Week Low 272.00
SPARC Important Levels
Resistance 2 511.40
Resistance 1 505.41
Pivot 496.45
Support 1 488.29
Support 2 482.30
NSE INDIA Most Active Stocks
RCOM 29.45 0.34%
JPASSOCIAT 21.70 4.08%
GMRINFRA 22.65 -0.44%
VISESHINFO 0.30 0.00%
UNITECH 9.05 2.84%
SUZLON 15.10 1.68%
ITC 274.55 0.42%
ITC 274.55 0.42%
RPOWER 48.90 0.41%
PNB 176.40 3.46%
More..
NSE INDIA Top Gainers Stocks
GSS 38.70 19.26%
GSS 38.70 19.26%
GSS 38.70 19.26%
GSS 38.70 19.26%
GRUH 687.80 15.00%
CYIENT 653.55 12.38%
ORIENTHOT 59.90 11.55%
TTL 122.35 11.38%
PALREDTEC 107.75 11.37%
ZENITHBIR 0.55 10.00%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.35 -12.50%
NAKODA 0.50 -9.09%
SEINV 338.00 -8.78%
INDOTHAI 101.40 -7.86%
DNAMEDIA 9.95 -7.44%
SPYL 0.70 -6.67%
JUBLINDS 249.70 -6.36%
TEJASNET 404.25 -6.32%
RAJRAYON 0.75 -6.25%
UTTAMSUGAR 120.20 -5.69%
More..

Sun Pharma Advanced Research Company Limited (NSE: SPARC)

SPARC Technical Analysis 5
As on 19th Jan 2018 SPARC Share Price closed @ 496.85 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 366.82 & Strong Buy for SHORT-TERM with Stoploss of 452.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
SPARC Target for January
1st Target up-side 562.47
2nd Target up-side 600.86
3rd Target up-side 639.25
1st Target down-side 452.93
2nd Target down-side 414.54
3rd Target down-side 376.15
SPARC Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 54.71 Sideways
MFI (14) MFI is 63.78 Sideways
CCI (20) CCI is -29.29 Sideways
WILLIAM %R (14) William %R is -73.69 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 531.14
10 Day Avg Volume Traded -44.98 % Less then 10 Day Average Volume
SPARC Other Details
Segment EQ
Market Capital 8430601728.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.sunpharma.in
SPARC Address
SPARC
Sun Pharma Advanced Research Centre
Akota Road
Vadodara, 390020
India
Interactive Technical Analysis Chart Sun Pharma Advanced Research Company Limited ( SPARC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sun Pharma Advanced Research Company Limited
SPARC Business Profile
Sun Pharma Advanced Research Company Limited operates as a pharma research and drug discovery company. It develops SUN 1334H, which has completed phase II clinical studies, used in the treatment of allergic disorders, such as seasonal and perennial allergic rhinitis, urticaria, hay fever, conjunctivitis, and pruritis; and Sun K706, a novel tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia. The company also offers SUN-597, an anti-inflammatory glucocorticoid that has completed preclinical development used for the treatment of allergic rhinitis, inflammation, asthma, and other applications; and Sun 44, a prodrug of gabapentin for the treatment of epilepsy, as well as for the treatment of neuropathic pain, restless leg syndrome, and mood disorders. In addition, it provides SUN-09, a prodrug of baclofen that has completed phase I studies for the treatment of spasticity; and SUN-L731, an oral LTD4 antagonist for asthma and allergic rhinitis. Further, the company offers gastro retentive innovative device, a once-a-day delivery system for drugs; wrap matrix oral delivery system; paclitaxel injection concentrate for nanodispersion for the treatment of breast cancer; docetaxel injection concentrate for nanodispersion for non-small cell lung cancer; and octreotide depot injections for treatment of prostate cancer and acromegaly. Additionally, the company provides salmeterol and fluticasone dry powder inhaler, a pre-metered inhalation activated device for administration of inhaled steroids and bronchodilator drugs for the treatment of asthma and COPD; swollen micelle microemulsion technology, a platform technology for solubilising ophthalmic drugs with limited or no water solubility; and gel free reservoir technology used for the treatment of chronic eye ailments, such as glaucoma. Sun Pharma Advanced Research Company Limited is based in Vadodara, India.